To study normative thresholds and latencies for click and toneburst auditory brainstem response (TB-ABR) for air and bone conduction in normal infants and those discharged from neonatal intensive care units, who passed newborn hearing screening and follow-up distortion product otoacoustic emission. An evoked potential system (Vivosonic Integrity) that incorporates Bluetooth electrical isolation and Kalman-weighted adaptive processing to improve signal to noise ratios was employed for this study. Results were compared with other published data.
INTRODUCTION
Congenital hearing loss is an important cause of developmental delay in speech, language, and social-emotional development. About 1 in 500 babies are born with permanent hearing loss, making it one of the one of the most common birth defects in developed countries (Ross et al. 2008; Watkin & Baldwin 2012) . About 8000 children are born in the United States each year with congenital hearing loss (White 2008) . In the past decade, universal newborn hearing screening (NHS) has reduced the mean age of diagnosis of all hearing loss from about 30 months prior to universal newborn screening to about 3 to 4 months in 2009 (Harrison & Roush 1996; Centers for Disease Control 2011; Watkin & Baldwin 2012) . In order to achieve the best outcomes for NHS programs, early and accurate diagnosis of congenital hearing loss is essential to allow appropriate and early intervention to lessen developmental sequelae (JCIH 2007) . The Joint Committee on Infant Hearing (JCIH), and participating organizations such as the American Academy of Pediatrics, American Academy of Otolaryngology, American Academy of Audiology, and the American Speech-Language Hearing Association, recommend the use of frequency-specific physiologic measures to diagnose hearing loss by no later than 3 months of age (JCIH 2007) .
Auditory brainstem response (ABR) is an electrophysiological measure used to predict hearing sensitivity in infants for whom reliable behavioral thresholds cannot be obtained, and it is currently the clinical standard for diagnosing degree and type of hearing loss in young infants unable to respond behaviorally (Stapells & Oates 1997; Gorga et al. 2006) . ABR testing was introduced in the 1970s as a physiologic tool to assess and diagnose disorders affecting the auditory pathways (Galambos & Hecox 1978; Schulman-Galambos & Galambos 1979; Galambos et al. 1984) . ABR tone-burst (TB) thresholds are highly correlated with behavioral audiometric thresholds (Stapells et al. 1995; Stapells 2000; Gorga et al. 2006; Vander Werff et al. 2009 ), and as such may be used to estimate hearing thresholds for the purpose of initiating amplification before validation with behavioral audiometry. The use of air conduction (AC) and bone conduction (BC) tone-burst ABR (TB-ABR) for hearing diagnosis in newborns has been advocated by the JCIH (2007) . Once the infant is developmentally able to respond reliably to sound, behavioral audiometry is the accepted gold standard for hearing function, but ABR testing is of particular importance in infants below 6 months of age (Mason et al. 1988) .
Despite the long history of the use of ABR in NHS and diagnostic programs, several problems in the clinical application of AC and BC TB-ABR have limited effective and timely 472 ELSAYED ET AL. / EAR & HEARING, VOL. 36, NO. 4, [471] [472] [473] [474] [475] [476] [477] [478] [479] [480] [481] diagnosis of all newborns referred from screening programs. Some audiologists believe that it is not feasible to obtain accurate frequency-specific ABR due to a lack of frequency specificity or neural synchrony (Stapells 2011; Baldwin & Watkin 2013) . Concerns about obtaining adequate recordings in naturally sleeping or quiet, awake infants and time required to obtain TB recordings have caused many audiologists to persist with using only click stimuli. There are also concerns about the accuracy of BC recordings. Despite a number of studies documenting the reliability and validity of BC recordings in infants (Yang et al. 1993a (Yang et al. , 1993b Small et al. 2007) , some clinicians believe BC testing is not feasible or accurate. A lack of consensus exists about how to couple the bone transducer to the infant's skull and whether and how to employ contralateral masking. In addition, threshold data are lacking for some TB frequencies, notably 1000 and 4000 Hz, which are important for defining the shape of the predicted audiogram (Hatton et al. 2012) . Normative data have been published for AC and BC TB-ABR testing, but most studies have consisted of retrospective clinical samples or infants who referred from NHS and were later deemed to have normal hearing (e.g., Vander Werff et al. 2009; Hatton et al. 2012) . Infants referred for clinical concerns do not represent a true normative population as failed newborn screening tests could be associated with mild hearing loss or middle ear problems; thus, the normative sample is affected by the clinical interpretation of what is considered "normal" after the test, rather than based on a set of a priori inclusion criteria.
Difficulties with obtaining adequate recordings in natural sleep in young infants can lead to delays in diagnosis. Loss to follow-up from NHS programs continues to be a challenge, with only 57% of infants who refer receiving a complete diagnostic evaluation by 3 months of age and 35% classified as lost to follow-up (Centers for Disease Control 2011). Thus, the ability to obtain a complete AC and BC ABR on the first attempt is highly desirable to achieve an early age of accurate diagnosis.
A major problem encountered in obtaining a high-quality recording in nonsedated infants is myogenic noise produced as the infant moves, suckles, or cries. Variable sleep state may cause increased myogenic noise; thus, the small auditory signal must be extracted from a background of larger myogenic and electrical signals. An improvement in signal to noise ratio (SNR) is traditionally obtained through a combination of signal averaging and rejection of recordings above a certain threshold value, called artifact rejection. However, when recordings are noisy, the time needed to acquire an averaged waveform is increased as many recordings may be rejected. An alternative approach is to retain these noisy recordings, but to weight them less than quiet recordings. This approach is known as "robust weighted averaging" (Leski 2002) .
A type of robust weighted averaging that has been applied to auditory-evoked responses is known as Kalman-weighted averaging (Marcoux & Kurtz 2012) . Kalman weighting is a recursive filter that estimates the true state of dynamically changing noisy measurements, so is well suited to applications such as auditory-evoked potentials which seek to extract low-level electrical signals within high background noise (Georgiadis et al. 2005) . This type of weighting has been developed in the Vivosonic Integrity system (Toronto, ON, Canada), a commercially available ABR instrument designed for use in pediatric diagnostic applications. A primary claim of the manufacturer is that ABR recordings can be obtained more readily in nonsedated infants. The instrument reduces electric and magnetic fieldinduced interference by using in-situ amplification on the ground electrode. The preamplifier, called the Amplitrode ® , has short, shielded leads to further isolate electrical contamination. Kalman weighting, as implemented in the Vivosonic system with digital filtering, further reduces electromagnetic artifacts and estimates the ABR signal by extracting the signal from each sweep, without rejection of artifacts as is done in traditional ABR systems. Instead, each response is weighted according to the estimated electrical noise, as derived from the prestimulus recording. This adaptive processing method provides cleaner waveforms by recalculating the weighting according to the relationship between covariance in sweeps and residual noise.
The electrodes are connected via a Bluetooth wireless interface, which reduces conducted electrical power contamination. An AC isolation transformer is used to reduce power-line noise. Normative ABR threshold data using this system are not currently available, and comparisons to thresholds published for other ABR test systems are needed. It is possible that ABR thresholds may be improved using this measurement system, but the effect of using Kalman weighting on measurements of ABR latency in infants has not been evaluated. In addition, the impact of sleep state has not been evaluated in this system, which purports to improve threshold estimates under less than optimal conditions. The primary goal of this study was to provide normative data for AC and BC TB-ABR thresholds for 500 to 4000 Hz. The normative group was defined as infants who passed the NHS exam and also passed a distortion product otoacoustic emission (DPOAE) test on the follow-up date on which the TB-ABR data were acquired. There is a lack of published normative data for AC and BC TB-ABR at 1000 and 4000 Hz; thus, these frequencies were prioritized. The following are the specific objectives of this study: 
MATERIALS AND METHODS

Subjects
This study is a part of a more extensive and ongoing longitudinal, prospective study of newborns and infants screened in normal nurseries and neonatal intensive care units (NICUs), funded by the National Institute of Deafness and other Communication Disorders. The overall goal is to improve accuracy of hearing screening to discriminate conductive hearing loss from sensorineural and neural hearing loss and to determine risk for recurrent/chronic otitis media with effusion.
Infants were enrolled from the well-baby nursery and NICU at Good Samaritan Hospital (GSH) and the NICU at Cincinnati Children's Hospital Medical Center (CCHMC), both urban hospitals in Cincinnati, OH. Table 1 summarizes the demographic characteristics of the infants included in the normal ABR analysis. A total of 145 infants (males = 89, females = 56) and 265 ears comprised the study sample, in which 120 infants were tested in both ears. Nineteen infants were recruited from the NICU and 126 from the well-baby nursery. The mean age at testing was 1.8 months (SD = 1.3), and the median age was 1.4 months, with a range of 0.8 to 6.9 months. While a few infants were older due to prematurity and the need to reschedule when they were healthy enough to travel for outpatient visits, 75% of subjects were tested at age 2 months or less. The sample reflects the race and ethnicity of the Cincinnati metropolitan area, with the majority of infants identified as white, non-Hispanic (65%), or African American (27%), as well as smaller numbers of Hispanic ethnicity and mixed race or other categories. Risk factors for hearing loss were reported in 28% of infants, while 13% had a NICU stay. Some of the babies in the normal newborn nursery had risk factors, such as family history of hearing loss, ear tags or pits, or brief courses of ototoxic drugs. Many of the infants cared for in the NICU had multiple risk factors; thus, the percentages for risk factors in Table 1 add up to more than 100%.
Test Protocol
The research protocol was approved by the Institutional Review Boards of CCHMC and GSH. The standard hospital newborn screening protocol was performed before enrollment so as not to interfere with the normal clinical process. After explanation of the study and agreement by the primary caregiver to participate via signed informed consent, infants were tested using a two-stage hearing screening protocol of transientevoked otoacoustic emission (TEOAE), followed by automated ABR (AABR) for infants who did not pass TEOAE. Infants in the GSH NICU were tested with both TEOAE and AABR, while infants in the CCHMC NICU were tested with DPOAE and manual click ABR rather than AABR. Infants who passed the two-stage hearing screening hospital protocol and returned for diagnostic ABR were selected for this normative study. Follow-up diagnostic ABR testing was scheduled at age 1 month, and preparation instructions for testing were sent to caregivers. Instructions included keeping the infant awake and delaying feeding until after arrival at the outpatient clinic. Testing was scheduled in synchronization with the infant's sleep schedule when possible. Infants were tested after bottle or breast feeding while resting in their caregiver's arms or in an infant carrier.
DPOAE testing using the Vivosonic Integrity system, Version 5.2 was performed prior to the diagnostic threshold ABR. Primary tone levels were set at 65 (L1) and 55 (L2) dB SPL, and primary tone frequencies f1 and f2 were set at f2/f1 equal to 1.22. In-situ calibration was performed before testing each ear, followed by a Distortion-Product (DP)-gram acquisition. Two trials were run and the overall better of the two tests was chosen to optimize SNR. Pass criteria were SNR of 6 dB or greater at 3 of 5 test (f2) frequencies (2000, 3000, 4000, 5500, and 8000 Hz) . In addition, DP levels were required to be at or above 0 dB SPL to reduce the possibility of mild hearing loss (Gorga et al. 2005) . Wideband absorbance and admittance tympanograms were also measured using a research system with custom software, although these results were not analyzed in the present report with one exception: wideband admittance tympanograms were examined at 1000 Hz to determine whether the compensated admittance was in a normal range. This normal range was a magnitude exceeding 0.6 mmho relative to the positive baseline, which is similar to the criterion used with a singlefrequency admittance test at 1000 Hz (Margolis et al. 2003) . Some ears (n = 39) were excluded due to not passing either DPOAE or 1000-Hz tympanometry.
The ABR diagnostic examination was conducted by licensed pediatric research audiologists within a shielded double-walled sound-attenuated booth, using the Vivosonic Integrity system, Version 5.2. Stimuli for AC were presented via insert earphones (Etymotic Research ER-3A, Elk Grove Village, IL) using pediatric ear foam tips, trimmed as necessary to accommodate newborn ear canals. BC stimuli were presented via a standard hand-held Radioear B-71 bone vibrator (Radioear Corp, New Eagle, PA), which was placed at the temporal bone at the superior postauricular area as recommended by Yang et al. (1987) and by Stuart et al. (1990) . Broadband contralateral masking was applied using ER-3A insert phones with a masker level 10 dB above the level of the test stimulus. Stimuli were presented at 37.1 per second using Blackman-gated tones with ramping of 2-0-2 cycles; thus, the rise/fall time was 4 msec at 500 Hz, 2 msec at 1000 Hz, 1 msec at 2000 Hz, and 0.5 msec at 4000 Hz. Reference values at 0 dB nHL for the ER-3A insert earphones in peak-equivalent sound pressure levels (peSPL) were 25 dB at 500 Hz, 26 dB at 1000 Hz, 31 dB at 2000 Hz, and 35 dB at 4000 Hz. The reference peSPLs at 0 dB nHL for the B-71 bone vibrator were 67, 54, 49, and 41 dB at 500, 1000, 2000, and 4000 Hz, respectively. The system was calibrated by the manufacturer prior to the study and annually. Independent acoustic calibration measurements (peak dB SPL in a standard 2-cc coupler) done by our laboratory for dB HL pure-tone conversion confirmed these values for insert earphones.
Signal averaging using the default Kalman weighting algorithm was employed, with the high-pass filter cutoff frequency set at 30 Hz and the low-pass filter cutoff frequency set at 3000 Hz. Rarefaction, condensation, and summed alternating averages were recorded in a "split alternating" protocol, which allowed comparison of polarities and the ability to correlate waveforms for reliability measures. The high forehead to ipsilateral mastoid recording montage was used with disposable pregelled electrodes, and interelectrode impedance was maintained at less than 5 K ohms. Clicks were delivered at 70 dB nHL, referenced to 38 dB peSPL to assess waveform morphology and latencies for waves I, III, and V. Tone-burst thresholds were collected for AC and BC at octave frequencies between 500 and 4000 Hz, starting at 4000 Hz, at 30 dB nHL, with initial steps of 20 dB higher or lower, depending on presence of wave V, decreasing after the first reversal to 10 dB steps to seek threshold. The next frequency tested was 1000 Hz, and then 500 and 2000 Hz as time and infant state allowed. The minimum test protocol was AC for 1000 and 4000 Hz and BC for at least one corresponding frequency. The rationale for selection of 1000 and 4000 Hz as the primary frequencies tested was that 500 Hz may show airbone gaps (ABGs) in normal-hearing infants (Vander Werff et al. 2009 ) and tends to be more difficult to distinguish at threshold. It was desirable to test a lower and higher frequency TB, to characterize presence, type, and shape of hearing loss for the larger study. The latency of wave V was recorded at all intensities. Stopping rules are necessary to improve confidence that a response is biologically present and not due to myogenic or electrical artifacts (Don & Elberling 1996) . Multiple decision criteria were constructed based on (1) logical latency-intensity functions, (2) correlation coefficients meeting specified criteria, (3) acceptable residual noise, and (4) interexaminer agreement. In order to determine the presence of wave V, split-half waveforms were compared using a correlation coefficient, set manually from the onset prior to wave V to the negative trough after wave V as shown in Figure 1 . The ongoing correlation value was tracked during the assessment with a stopping rule of visual acceptance of the waveform by the testing audiologist and correlation of 0.7 or higher, to indicate high probability of a nonrandom response (Sokolov et al. 2008) . Rarefaction and condensation waveforms were subtracted to determine when the residual noise was low relative to the averaged waveform and in the case of threshold responses, ideally below 0.05 μV or 50 nV (Don & Elberling 1996) . Normally, 2000 to 4000 averages were obtained, but a minimum of 1000 averages were accepted if the waveform was clearly present within an expected latency region, correlations were high, and residual noise was low. In addition, the waveforms were examined by a second audiologist experienced in ABR measurements to concur with the presence and latency of marked waveforms. If the threshold interpretation was not in agreement, the next higher intensity marked was used for wave V threshold. It is possible that lower thresholds could have been achieved with longer averaging, but these criteria were designed as a reasonable balance between time and accuracy and to be clinically realistic for naturally sleeping infants.
Statistical Analysis
Wave V threshold and latency values were analyzed for mean and standard deviation, and median and percentiles to establish normative ranges. Median levels are helpful for clinical use because the 10 dB step size used for our testing and by many clinicians does not correspond with the mean levels, thus the median provides clinically useful normative values. Previous studies have reported mean values, regardless of step size, so mean values were also calculated to allow comparison to published studies. Mean differences between the present study and published data were tested using the Student t test represented as mean ± SD. Differences in median values were tested using a nonparametric Wilcoxon rank sum test. When available, raw data from the publications were used in the analysis; otherwise, Fig. 1 . Typical click and tone-burst auditory brainstem response recording from the left ear of an infant aged 5 wks for clicks, 4000 and 1000 Hz for air conduction (left panel) and bone conduction (right panel). Correlation coefficients (R values) are shown above each waveform. Wave V is marked for each set of waveforms (rarefaction, condensation, and alternating), along with the region used to calculate the correlations from peak to trough of wave V, indicated by the statistical start and statistical end markers before and after the onset of the wave V component. Residual noise waveforms (A-B) are also shown below each set of bone conduction recordings. statistical comparisons were done using the published summary statistics. Because the limited number of multiple tests (multiple comparisons between published and study data across frequencies and intensities) introduced a risk of a type I error, statistical significance for analyses with multiple tests was evaluated using a Bonferroni correction. Mean threshold differences between ears and gender were tested using the Student t test as well. As measurements were taken on the same infant/ ear across frequencies, linear mixed models were used to assess changes across frequencies (repeated measures -within-subject variation) while testing for ear, gender, and age effects. Random effects were used to account for multiple measurements (multiple frequencies) on the same subject. Different covariance models were considered, and compound symmetry was selected based on model fit. Separate models were constructed on AC and BC measurements for both threshold and latency values. In the event of a statistically significant finding, an interaction term between frequency and that significant factor (e.g., Frequency × Gender) was tested in the model. Results were analyzed in the final model for ear, gender, age, and frequency.
RESULTS
Typical recordings of AC and BC TB-ABR for 1000 and 4000 Hz from an infant aged 5 weeks of age are shown in Figure 1 . The intensity steps used for recording are shown, at 70 dB nHL for clicks and starting at 30 dB nHL for tone bursts. Wave V cross-correlations (R) are shown for each waveform, along with the statistical start and statistical end used to calculate the correlations for wave V. The statistical start and statistical end were placed manually before the onset of wave V to the offset (trough) for consistency. In each set of overlapped waveforms, separate polarity and alternating (combined) waveforms are shown. The stimulus artifact and cochlear microphonic (where present) can be seen within the first 1 to 2 msec of the recording. The neural components (waves I, III, and V) were marked if the correlation was adequate (R values are shown by each panel of responses). Residual noise recordings are also shown for BC recordings to show that responses obtained were not the result of myogenic or other noise.
For all ears included in the study, Figure 2 shows the mean and standard deviation for click ABR components and Figure 3 shows box and whisker plots for AC and BC wave V thresholds at the octave test frequencies from 500 to 4000 Hz. The box overlaps the whiskers at some frequencies in Figure 3 due to the non-normal distribution. Cumulative percentiles were constructed to determine normative ranges for each frequency and are shown in Figures 4 and 5 for AC and BC, respectively. Functions were fit to determine optimal cut points for normal ABR threshold based on the 95th percentile. Normative threshold values recommended for clinical application, along with other descriptive statistics, are provided in Table 2 for AC, BC, and ABG. The median ABG was 0 at all frequencies, and the 95th percentile was 20 dB at 500 and 1000 Hz, decreasing to 0 dB at 2000 Hz and 10 dB at 4000 Hz, validating the presence of normal hearing in this group of infants. Note that negative numbers in ABG indicate that the BC threshold was worse than the AC threshold. The number of test ears at each frequency varied due to the protocol that tested first at 4000 and 1000 Hz and then at other frequencies, depending on the time remaining and the infant state.
Results of linear mixed models for AC are provided in Tables 3 and 4 . Wave V tone-burst thresholds had an overall significant decrease with increasing frequencies (p < 0.0001), as thresholds were better for higher frequencies. In contrast, BC 
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ELSAYED ET AL. / EAR & HEARING, VOL. 36, NO. 4, [471] [472] [473] [474] [475] [476] [477] [478] [479] [480] [481] wave V tone-burst thresholds significantly increased (p = 0.003) with increasing frequencies, particularly at 4000 Hz. There were no significant effects of age, ear, or gender on AC or BC thresholds, thus no apparent need for separate normative data for ear or gender or within the age range birth to 6 months. The latency of wave V was also analyzed in linear mixed models, as detailed in Table 4 . Wave V latency decreased with increasing stimulus intensity as expected between 10 and 30 dB nHL for both AC and BC tests. There was also a significant decrease in latency as expected for higher frequencies, due to shorter cochlear travel time to the basal regions tuned to higher frequencies. There were no significant age or ear effects on latency, but there was an effect of gender at the lowest intensity (10 dB nHL), with shorter latencies for females.
The mean wave V thresholds for this study were compared with similar published studies and are shown in Fig. 7) showed no difference at 500 Hz, while the present study found significantly better thresholds at 2000 Hz. BC thresholds in the present study at 1000 and 4000 Hz were not compared because of the lack of previously published normative data at these frequencies. It should be noted that the mean and SD calculated from raw data in the appendices from Vander Werff et al. are slightly different from the summary tabled values at 2000 and 4000 Hz for AC, but we used the raw data to calculate statistical significance. The differences in the summary and raw data for Vander Werff et al. are less than 1 dB, so should not affect statistical comparisons with the present study.
The differences found in the present study, while statistically significant, were within the intensity step size of 10 dB. Differences in calibration values for the Vivosonic system and subject selection for other published studies may account for the differences found. While small differences exist, threshold responses obtained using the Kalman weighting software were within the 10 dB step size of other published studies using traditional signal averaging methods.
Mean AC and BC wave V latencies were also compared with latencies from the study by Vander Werff et al. (2009) . Table 6 shows mean latency results from the present study along with the results of the statistical analysis comparing mean latencies in the two studies. For AC latencies, differences were not systematic; there were significant differences for 500 Hz at 20 dB, for 2000 Hz at 30 dB, and for 4000 Hz at 10 dB. Otherwise, mean latencies were similar in these studies, although the limited data at some frequencies and intensities reported by Vander Werff et al. precluded a direct statistical comparison. For BC latency comparisons (Table 6 ), significant differences were found at 500 for all intensities, with the present study showing slightly longer latency values. At 2000 Hz, a significantly longer latency was found in the present study only at 10 dB nHL. BC latencies were not compared at 1000 and 4000 Hz due to a lack of any previously published normative data at these frequencies.
Sleep state may be related to ABR results and was recorded in this study by the test audiologist as variable sleeping/awake in 58% of infants, sleeping in 27%, awake and moving in 5%, awake and fussy in 4%, and awake and quiet in 2%. Sleep state was not recorded in 4% of infants. Analysis of sleep state on threshold and latency values showed no significant effect on AC latency at 10 or 30 dB nHL (p = 0.21 and p = 0.92, respectively). For BC, a significant effect was found for sleep state latency at 10 dB HL (awake and fussy), with slightly poorer latency values compared with other sleep states (p = 0.0055). However, there was no effect of sleep state on BC at 30 dB nHL (p = 0.25).
DISCUSSION
In order to achieve high reliability and timely detection of congenital hearing loss, clinical diagnostic tools that are optimized for infant hearing screening follow-up are critical. ABR threshold testing can provide the audiologist with valuable information about an infant's sensorineural hearing loss to initiate treatment with amplification if frequency-specific stimuli are employed. The overall goal of this study was to improve the accuracy of hearing screening in infants by developing a clinical standard for diagnostic TB-ABR thresholds in naturally sleeping infants. This goal was achieved by measuring thresholds for AC and BC at four octave intervals between 500 and 4000 Hz. Previous studies have not provided normative data across the frequency range for both AC and BC stimuli using a clinically applicable protocol. In addition, previous studies have not included a normative sample of infants who passed NHS and a follow-up comparison test, which was a DPOAE test in this study. Strengths of this study included a longitudinal, The number of ears tested varied with frequencies. The 95th percentile was extrapolated from cumulative distribution graphs to the nearest 5 dB value between adjacent levels at 10 dB increments. ABG, air-bone gap; AC, air conduction; BC, bone conduction.
prospective design to acquire data in a large sample of infants enrolled and screened in both normal nurseries and NICUs. ABR testing was performed at both screening hospital and outpatient follow-up visits. The study population was diverse and reflective of Ohio demographic characteristics. The 95th percentile is recommended as normative cutoff for ABR thresholds at each frequency and is similar to those recommended. For AC, the normal cutoff value decreases with frequency, from 35 dB nHL at 500 Hz to 20 dB nHL at 4000 Hz. To decrease test time, AC stimulus levels might initially start at 30 dB nHL for stimuli between 1000 and 4000 Hz and decrease in a 10 dB step size. If responses were present at both levels within the expected latency range, the ABR would be considered normal. Testing at 1000 and 4000 Hz provides assessment across the most important audiometric range for speech perception. Responses at these frequencies are generally more defined and less prone to interference from myogenic activity than at 500 Hz, and they reveal the presence and configuration of both conductive and sensorineural hearing loss. We found that testing at 1000 and 4000 Hz is a time-efficient procedure to identify ears at risk for hearing loss. Moreover, the presence of wave V is often more difficult to ascertain at 500 Hz due to the broad, shallow morphology characteristics at that frequency. Clinical cutoffs for BC wave V threshold suggested from this study are 30 dB at 500 Hz, 30 dB at 1000 Hz, 25 dB at 2000 Hz, and 35 dB at 4000 Hz. On comparing mean AC and BC thresholds, BC thresholds were better than AC thresholds at 500 Hz, similar at 1000 and 2000 Hz, and worse at 4000 Hz.
Use of BC was found to be highly feasible in this study and just as reliable as AC in terms of cross-correlation values and residual noise (shown for a typical case in Fig. 1) . Two pilot methods were tested for applying the BC transducer to the infant's head. In the initial phases of the study, we tried using an elastic headband with a Velcro fastener and experimented with several types, including a bone-anchored hearing aid soft band to hold the B71 transducer. The elastic headband methods proved to be difficult to manage, as they would slip off the infant's head when enough pressure was applied to achieve adequate force, as measured using a force transducer. We switched to hand-holding the transducer, based on previous research that has reported acceptable reliability with hand-held measurements (Small et al. 2007 ). We found a distinct advantage in that the examiner could feel if the transducer was slipping at any point in order to pause averaging.
In a sidearm procedural study, thresholds were measured with the hand-held method in 12 infants in two conditions, with and without measurement of force using a calibrated force transducer designed by Etymotic Research. Wave V thresholds were first measured without using the force transducer and then measured using the force transducer. No significant differences in mean thresholds were found at 1000 or 4000 Hz. We found the handheld technique to be just as accurate and more convenient, in which either the audiologist or a trained assistant held the transducer firmly at the temporal bone above the ear with a fingertip.
No effect of age, ear, or gender was found on wave V thresholds, suggesting that normative values may be collapsed. While no significant effect of risk factors was found, the small NICU sample size precluded any firm conclusions about normal ranges in high-risk infants. There were no significant effects of age or gender on latency, except for gender at 10 dB nHL.
Four previous published studies have reported normative TB-ABR thresholds in the infant age group. The age range was 1 week to 8 years in Stapells et al. (1995) , 2 weeks to 13 Fig. 6 . Comparison of the mean and SD for air conduction (AC) tone-burst auditory brainstem response thresholds for the present study and previous studies in infants. that measured TB-ABRs with a Bio-Logic system (Vander Werff et al. 2009 ). A similar comparison was performed for BC TB-ABR latencies measured at 500 and 2000 Hz. Significantly longer latency differences at 500 Hz were found for intensities from 10 to 30 dB nHL. Thus, there may be an impact of the weighting algorithm for lower frequency stimuli, but this would require a direct comparison with and without weighting to determine. The fact that latency values were generally similar to those reported by Vander Werff et al. (2009) for most intensity levels is evidence for similarity in auditory and neural function between the populations in the two studies and demonstrates that calibration values are unlikely to explain the threshold differences we found, as higher intensity stimuli would result in shorter latencies, not longer. months in Foxe & Stapells (1993) , and less than 2 years in Stapells (2000) . Similar to our study, Vander Werff et al. (2009) measured the ABR thresholds in normal-hearing infants less than 3 months old. As depicted in Figures 6 and 7 , our AC and BC results showed slightly lower (better) mean thresholds at the three frequencies studied compared with the results by Vander Werff et al. These mean threshold differences may be explained in part by our subject population, who all passed NHS and follow-up DPOAE testing. In addition, the Vivosonic reference calibration values were higher than the comparative studies. Comparisons for latency across a range of frequency and intensity were similar in our study for AC-TB at most intensities and were generally consistent with trends from a previous study This study used a conservative approach for determining the presence of wave V, in which a high cross-correlation, low residual noise level, and agreement in data interpretation between two audiologists were required. While it is not clinically feasible to require agreement between two audiologists for every recording, training and quality control could ideally include this approach for a subset of recordings. Use of online correlational analysis and examining the residual noise are highly desirable quality controls for clinical reliability and might be considered when selecting equipment for clinical use.
In pilot testing, we measured thresholds in the NICU environment infants for click and TB stimuli were compared using the Bio-Logic and Vivosonic systems. Slightly better thresholds were measured for clicks and TB stimuli at 500 and 1000 Hz for the Vivosonic system reported here compared with published studies in other systems. Inter-test agreement in the pilot testing showed click thresholds within 10 dB for 15/20 ears (75% agreement) and thresholds of 10 to 20 dB better in the Vivosonic system in 5/20 ears (25%). No thresholds were higher with the Vivosonic system.
A primary claim of the manufacturer of the Vivosonic Integrity system is the ability to achieve adequate recordings in awake infants. While it is always ideal to record in sleeping or sedated infants, the results of this study showed the ability to successfully record thresholds in awake quiet infants when an adequate sleep was not achieved. In the fussy state, recordings were paused until the infant stopped crying; thus, the majority of recordings were in variable awake/sleeping infants. Notably, threshold and latency values were not significantly affected by sleep state, except at 10 dB for BC latency.
CONCLUSIONS
This study measured normative values in young infants for AC and BC TB-ABR thresholds, as well as for the ABG for wave V. Low intensity thresholds were successfully obtained for masked BC with a hand-held bone vibrator over the temporal bone in infants. The large normal sample size tested across frequencies (500 to 4000 Hz) is a strength of the study and estimates the distribution of responses expected in a normal population that passed NHS and were tested under typical clinical conditions in natural sleep. We found that clicks at 70 dB nHL and AC-BC TB-ABR thresholds for both ears at 1000 and 4000 Hz could be completed in nearly all cases regardless of sleep state. Overall, the results of this study using a Vivosonic system for latency-intensity functions were similar to previous studies using a Bio-Logic system for 500, 2000, and 4000 Hz. The primary advantage of the Vivosonic system was the demonstrated ability to successfully measure AC and BC thresholds in both ears at multiple frequencies in lightly sleeping or awake infants in less than 1.5 hr, including time for explanations, feeding, otoacoustic emission, and wideband immittance.
